• NPPA'S HELPLINE NO. 1800111255


(Published in Part II, Section 3, Sub-section (ii) of

the Gazette of India, Extraordinary, dated the 30th November, 2007)

Government of India

Ministry of Chemicals and Fertilizers

National Pharmaceutical Pricing Authority

New Delhi, the 30th November, 2007


S.O. 2057(E)- In partial modification to S.O. No. 1636(E) dated 27th September, 2007 the entries in the table at Sr. No. 4 and 12 may be read as :


Sl. No. Name of the formulation Strength Pack   Size Ceiling Price (Rs.) Equivalent MRP*  inclusive  of all taxes  (Rs.)
 (1)  (2)  (3)  (4)  (5)  (6)



Each gm contains




1 Betamethasone+ Chlorocresol Ointment  Betamethasone-0.0125%  Chlorocresol-0.10%  17gm  Tube  7.32  8.44



 Each ml contains




2  Betamethasone+  Chlotrimaxole Lotion  Betamethasone-0.05% w/v   Chlotrimaxole-1.00% w/v  16ml   Container 8.98  10.36”

*Subject to actual payment of Government levies/taxes, as applicable.

 Note :

(a)        The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5).  If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c)        Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated 27.1.1998 for tablet and capsule packed in strip/blister.

(d)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(e)        The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

(f)         The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(g)        Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the following price order(s) issued prior to this date of notification stand automatically withdrawn :

Sl.No. Price Order No. Date



and any other price order(s) issued earlier for the composition of the formulation pack for which ceiling price is notified in this notification.


F. No. 8(7)/2007/D.P./NPPA-Div.-II

                                                                                                              (RAJIV WADHAWAN)

                                                                                                                     Deputy Director

Last Page Updated: 01-06-2019